We demonstrated that miR-93 promoted HCC cell proliferation, migration and invasion through activation of the oncogenic c-Met/PI3K/Akt pathway, and also inhibited apoptosis and drug-sensitivity by directly inhibiting PTEN and CDKN1A expression in HCC cells. Here, MET is linked to hepatocellular carcinoma.